The Democratic Republic of Congo (DRC) today is caught in a convulsive spiral of violence and institutional decay that lays bare a cruel paradox of both subterranean abundance and surface‑level ...

Backed by a $1M+ commercial license and 1B+ solutions evaluated, Project 777 is moving frontier AI from raw model ...

After founding the "Google for LLMs," You.com, Richard Socher's next company, Recursive AI, could automate AI research itself ...

Major release delivers seamless Ignition SCADA, enterprise-grade security, advanced ML algorithms, and private cloud ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Boolean options: -n, --dry-run Don't actually minify the file(s), just show if they will be processed. -d, --include-dotfolders Include dotfolders in file search. -D, --include-dotfiles Include ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Recursion Pharmaceuticals, Inc. is one of them. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a ...